arginine and paclitaxel

arginine has been researched along with paclitaxel in 43 studies

Research

Studies (43)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	15 (34.88)	18.2507
2000's	12 (27.91)	29.6817
2010's	16 (37.21)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bonfoco, E; Ceccatelli, S; Manzo, L; Nicotera, P	1
Moscarello, MA; Pritzker, LB	1
Choi, SH; Chun, BG; Chun, YS; Kang, H; Kang, SW; Min, BH; Park, IS; Shin, KH	1
Kirschberg, TA; Rothbard, JB; VanDeusen, CL; Wender, PA; Yang, M	1
Dansette, PM; Jaouen, M; Johnson, EF; Macherey, AC; Mansuy, D; Marques-Soares, C; Melet, A; Sari, MA; Schoch, GA	1
Crook, T; Hiller, L; Kimberley, C; Koensgen, D; Mustea, A; Nicholson, LJ; Schmid, P; Sehouli, J; Smith, PR; Szlosarek, PW	1
Bhat, NM; Bieber, MM; Galliher, WC; Pillow, TH; Teng, NN; Wender, PA	1
Cao, F; Huang, A; Li, H; Li, S; Ping, Q; Su, Z; Sun, M; Xiao, Y; Zhang, C	1
Kim, PH; Kim, SW; Nam, HY; Nam, K	1
Gota, V; Mehta, M; Patel, K; Patil, A; Vavia, P	1
Ramanathan, K; Verma, K	1
Cao, W; Gao, G; Gu, Y; Li, S; Liu, M; Shan, L; Wu, C; Xu, L; Zhao, L	1
Nurcahyanti, AD; Wink, M	1
Duncan, B; Hou, S; Jeong, Y; Jiang, Y; Kim, C; Kim, CS; Kim, ST; Park, MH; Rotello, VM; Saha, K; Tang, R; Yan, B; Yeh, YC	1
Bi, X; Cai, X; Dai, Y; Huang, W; Li, H; Lin, H; Pan, M; Qian, H; Shi, W; Su, X	1
Li, Q; Liang, N; Sun, S; Yan, C; Yan, P	1
Weiss, RB	1
Grant, SC; Kris, MG	1
Meyer, C	1
Debruyne, C; Giaccone, G; Postmus, PE; Sahmoud, T; Splinter, TA; van Zandwijk, N	1
Ardizzoni, A; Debruyne, C; Diaz-Puente, M; Giaccone, G; Postmus, PE; Scagliotti, G; Splinter, TA; Van Meerbeeck, J; Van Zandwijk, N	1
Lundberg, BB	1
Ghaemmaghami, M; Jett, JR	1
Curran, D; Debruyne, C; Giaccone, G; Kho, GS; Lianes, P; Pennucci, MC; Postmus, PE; Sahmoud, T; Scagliotti, G; Splinter, TA; van Hoesel, Q; van Meerbeeck, J; van Zandwijk, N	1
Durka, S; Hueber, A; Weller, M	1
de Jong, S; Le, TK; Mulder, NH; Sleijfer, S; Timmer-Bosscha, H; Withoff, S	1
Bartussek, C; Naumann, U; Weller, M	1
Annemans, L; Giaccone, G; Vergnenègre, A	1
Belani, CP; Calvo, AR	1
Dingemans, AC; Giaccone, G; Postmus, PE; Scagliotti, GV; Span, S; van Ark-Otte, J; van der Valk, P	1
Chen, W; Guo, W; Lin, L; Xu, Q; Zhou, X	1
Bunn, PA; Simon, GR	1
Di, X; Dumur, C; Elmore, LW; Gewirtz, DA; Holt, SE	1
Beijnen, JH; Bussink, J; Huitema, AD; Punt, CJ; Timmer-Bonte, JN; Tjan-Heijnen, VC; van Die, CE; vd Heijden, HF	1
Pagani, M	1
Brown, JB; Kadoyama, K; Kuwahara, A; Okuno, Y; Sakaeda, T; Yamamori, M	1

Reviews

7 review(s) available for arginine and paclitaxel

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Hypersensitivity reactions. Seminars in oncology, 1992, Volume: 19, Issue:5 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Aziridines; Benzoquinones; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Hypersensitivity; Etoposide; Fluorouracil; Humans; Ifosfamide; Melphalan; Methotrexate; Mitomycins; Neoplasms; Paclitaxel; Pentostatin; Procarbazine; Teniposide	1992
New antineoplastic agents in lung cancer 1988-1993. Cancer treatment and research, 1995, Volume: 72 Topics: Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Humans; Irinotecan; Lung Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds; Paclitaxel; Teniposide; Vinblastine; Vinorelbine	1995
New agents in the treatment of small cell lung cancer. Chest, 1998, Volume: 113, Issue:1 Suppl Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Drugs, Investigational; Gemcitabine; Humans; Immunologic Factors; Irinotecan; Lung Neoplasms; Menogaril; Paclitaxel; Taxoids; Teniposide; Topotecan; Treatment Outcome; Vinblastine; Vinorelbine	1998
Lung cancer: therapeutic options for stage IV and recurrent NSCLC. Cancer treatment and research, 2001, Volume: 105 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Deoxycytidine; Docetaxel; Etoposide; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate; Taxoids; Teniposide; Treatment Outcome; Vinblastine; Vinorelbine	2001
Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments. Cancer investigation, 2003, Volume: 21, Issue:1 Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Docetaxel; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Microtubules; Multicenter Studies as Topic; Neoadjuvant Therapy; Organoplatinum Compounds; Paclitaxel; Palliative Care; Podophyllotoxin; Randomized Controlled Trials as Topic; Salvage Therapy; Survival Analysis; Taxoids; Teniposide; Treatment Outcome; Vinblastine; Vinorelbine	2003
The complex clinical picture of presumably allergic side effects to cytostatic drugs: symptoms, pathomechanism, reexposure, and desensitization. The Medical clinics of North America, 2010, Volume: 94, Issue:4 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Asparaginase; Carboplatin; Cisplatin; Cytostatic Agents; Desensitization, Immunologic; Docetaxel; Drug Hypersensitivity; Humans; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Procarbazine; Risk Factors; Taxoids; Teniposide	2010

Trials

6 trial(s) available for arginine and paclitaxel

Article	Year
Results of the phase II EORTC study comparing paclitaxel/cisplatin with teniposide/cisplatin in patients with non-small cell lung cancer. EORTC Lung Cancer Cooperative Group. Seminars in oncology, 1996, Volume: 23, Issue:5 Suppl 12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Teniposide	1996
Cisplatin/paclitaxel vs cisplatin/teniposide for advanced non-small-cell lung cancer. The EORTC Lung Cancer Cooperative Group. The European Organization for Research and Treatment of Cancer. Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:4 Suppl 3 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Lung Neoplasms; Middle Aged; Paclitaxel; Survival; Teniposide; Treatment Outcome	1997
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Quality of Life; Random Allocation; Survival Rate; Teniposide; Treatment Outcome	1998
[New perspectives in the treatment of bronchial cancer. Pan-European Lung Cancer Forum: "New perspectives on the Management of Lung Cancer". Sitges/Barcelona, 14 March 1998]. Pneumologie (Stuttgart, Germany), 1998, Volume: 52, Issue:5 Suppl Ne Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Cisplatin; Humans; Lung Neoplasms; Paclitaxel; Teniposide	1998
The cost-effectiveness of paclitaxel (Taxol) + cisplatin is similar to that of teniposide + cisplatin in advanced non-small cell lung cancer: a multicountry analysis. Anti-cancer drugs, 1999, Volume: 10, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Belgium; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cost-Benefit Analysis; Costs and Cost Analysis; France; Humans; Lung Neoplasms; Netherlands; Paclitaxel; Spain; Teniposide	1999
Prophylactic G-CSF and antibiotics enable a significant dose-escalation of triplet-chemotherapy in non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2008, Volume: 60, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Teniposide	2008

Other Studies

30 other study(ies) available for arginine and paclitaxel

Article	Year
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Colchicine induces apoptosis in cerebellar granule cells. Experimental cell research, 1995, Volume: 218, Issue:1 Topics: Amino Acid Oxidoreductases; Animals; Apoptosis; Arginine; Calcium; Cell Survival; Cells, Cultured; Cerebellum; Colchicine; Cyclosporine; Dizocilpine Maleate; DNA; Kinetics; Neurons; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Paclitaxel; Rats; Rats, Sprague-Dawley; tau Proteins; Time Factors; Tubulin	1995
A novel microtubule independent effect of paclitaxel: the inhibition of peptidylarginine deiminase from bovine brain. Biochimica et biophysica acta, 1998, Oct-14, Volume: 1388, Issue:1 Topics: Animals; Arginine; Brain; Cattle; Enzyme Inhibitors; Hydrolases; Kinetics; Microtubules; Myelin Basic Protein; Paclitaxel; Protein Binding; Protein-Arginine Deiminase Type 4; Protein-Arginine Deiminases	1998
Cytoprotective effect of arginine deiminase on taxol-induced apoptosis in DU145 human prostate cancer cells. Molecules and cells, 2000, Jun-30, Volume: 10, Issue:3 Topics: Amino Acid Sequence; Animals; Apoptosis; Arginine; Astrocytes; Cell Line; Culture Media, Conditioned; Cycloheximide; Cytoprotection; DNA Fragmentation; G1 Phase; Humans; Hydrolases; L-Lactate Dehydrogenase; Lipopolysaccharides; Male; Molecular Sequence Data; Nitric Oxide; Paclitaxel; Prostatic Neoplasms; Protein Synthesis Inhibitors; Rats; Sequence Alignment; Sertoli Cells; Tumor Cells, Cultured	2000
Arginine-based molecular transporters: the synthesis and chemical evaluation of releasable taxol-transporter conjugates. Organic letters, 2003, Sep-18, Volume: 5, Issue:19 Topics: Acetylation; Antineoplastic Agents; Arginine; Half-Life; Hydrogen-Ion Concentration; Membrane Transport Proteins; Molecular Structure; Paclitaxel; Solubility; Stereoisomerism	2003
Analysis of human cytochrome P450 2C8 substrate specificity using a substrate pharmacophore and site-directed mutants. Biochemistry, 2004, Dec-14, Volume: 43, Issue:49 Topics: Amiodarone; Animals; Arginine; Aryl Hydrocarbon Hydroxylases; Asparagine; Catalysis; Chromans; Computer Simulation; Cytochrome P-450 CYP2C8; Diclofenac; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Isoleucine; Models, Molecular; Mutagenesis, Site-Directed; Paclitaxel; Phenylalanine; Rabbits; Serine; Substrate Specificity; Sulfonamides; Thiazolidinediones; Tretinoin; Troglitazone	2004
Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer. International journal of cancer, 2009, Sep-15, Volume: 125, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Arginine; Argininosuccinate Synthase; Carboplatin; Cell Death; Cisplatin; Cystadenocarcinoma, Serous; DNA Methylation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Immunoblotting; Middle Aged; Ovarian Neoplasms; Paclitaxel; Promoter Regions, Genetic; Survival Rate; Tumor Cells, Cultured	2009
Taxol-oligoarginine conjugates overcome drug resistance in-vitro in human ovarian carcinoma. Gynecologic oncology, 2012, Volume: 126, Issue:1 Topics: Aged; Aged, 80 and over; Arginine; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Oligopeptides; Ovarian Neoplasms; Paclitaxel; Prodrugs	2012
An arginine derivative contained nanostructure lipid carriers with pH-sensitive membranolytic capability for lysosomolytic anti-cancer drug delivery. International journal of pharmaceutics, 2012, Oct-15, Volume: 436, Issue:1-2 Topics: Animals; Antineoplastic Agents, Phytogenic; Arginine; Cell Line, Tumor; Cell Membrane; Cell Survival; Cells, Cultured; Drug Carriers; Erythrocytes; Hemolysis; Humans; Hydrogen-Ion Concentration; Lipids; Lysosomes; Male; Mice; Nanoparticles; Neoplasms; Paclitaxel; Rats; Serum Albumin, Bovine; Tissue Distribution	2012
Paclitaxel-conjugated PEG and arginine-grafted bioreducible poly (disulfide amine) micelles for co-delivery of drug and gene. Biomaterials, 2012, Volume: 33, Issue:32 Topics: Animals; Antineoplastic Agents, Phytogenic; Arginine; Breast Neoplasms; Cell Line, Tumor; DNA; Female; Glutathione; Humans; Interleukin-12; Mice; Micelles; Paclitaxel; Particle Size; Polyamines; Polyethylene Glycols; Transfection	2012
Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity. International journal of pharmaceutics, 2014, Sep-10, Volume: 472, Issue:1-2 Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Arginine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chickens; Clarithromycin; Cyclosporine; Cytochrome P-450 CYP3A Inhibitors; Drug Compounding; Gastrointestinal Tract; Hypromellose Derivatives; Ileum; Melanoma, Experimental; Mice; Nanoparticles; Paclitaxel; Particle Size; Rats, Sprague-Dawley; Skin Neoplasms; Surface Properties; Tumor Burden	2014
Investigation of Paclitaxel Resistant R306C Mutation in β-Tubulin—A Computational Approach. Journal of cellular biochemistry, 2015, Volume: 116, Issue:7 Topics: Antineoplastic Agents, Phytogenic; Arginine; Binding Sites; Computational Biology; Cysteine; Drug Resistance, Neoplasm; Humans; Hydrogen Bonding; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Paclitaxel; Protein Binding; Protein Stability; Tubulin	2015
Multi-small molecule conjugations as new targeted delivery carriers for tumor therapy. International journal of nanomedicine, 2015, Volume: 10 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Arginine; Cell Line, Tumor; Cell Survival; Chemical Phenomena; Drug Carriers; Female; Fluorescein-5-isothiocyanate; Folic Acid; Glutamic Acid; HEK293 Cells; Humans; Lethal Dose 50; Male; Mice; Mice, Nude; Molecular Weight; Neoplasms; Paclitaxel; Prodrugs; Solubility; Toxicity Tests, Acute; Xenograft Model Antitumor Assays	2015
Cytotoxic potentiation of vinblastine and paclitaxel by L-canavanine in human cervical cancer and hepatocellular carcinoma cells. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2015, Dec-15, Volume: 22, Issue:14 Topics: Antineoplastic Agents, Phytogenic; Arginine; Canavanine; Drug Synergism; HeLa Cells; Hep G2 Cells; Humans; Paclitaxel; Vinblastine	2015
Nanoparticle-dendrimer hybrid nanocapsules for therapeutic delivery. Nanomedicine (London, England), 2016, Volume: 11, Issue:12 Topics: Animals; Antineoplastic Agents, Phytogenic; Arginine; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Dendrimers; Female; Gold; Melanoma; Mice; Mice, Inbred C57BL; Nanocapsules; Nanoparticles; Paclitaxel; Thiocarbamates	2016
Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane. Amino acids, 2017, Volume: 49, Issue:9 Topics: Amino Acid Sequence; Antimicrobial Cationic Peptides; Antineoplastic Agents; Apoptosis; Arginine; Caspase 3; Cell Membrane; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Expression; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Hydrophobic and Hydrophilic Interactions; K562 Cells; Lysine; MCF-7 Cells; Membrane Potential, Mitochondrial; Paclitaxel; Structure-Activity Relationship	2017
Biotin and arginine modified hydroxypropyl-β-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel. Carbohydrate polymers, 2019, Jul-15, Volume: 216 Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; Arginine; Biotin; Carcinoma; Drug Carriers; Female; Humans; MCF-7 Cells; Mice; Nanoparticles; Paclitaxel; Particle Size; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays	2019
On the oncology front. The American journal of nursing, 1993, Volume: 93, Issue:3 Topics: Child; Female; Humans; Ovarian Neoplasms; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide	1993
Ether lipids enhance the cytotoxic effect of teniposide and paclitaxel in liposomes against leukaemic cells in culture. Anti-cancer drug design, 1997, Volume: 12, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Drug Antagonism; Drug Synergism; Hemolysis; HL-60 Cells; Humans; Jurkat Cells; Liposomes; Paclitaxel; Phospholipid Ethers; Phosphorylcholine; Teniposide	1997
CD95-mediated apoptosis: no variation in cellular sensitivity during cell cycle progression. FEBS letters, 1998, Aug-07, Volume: 432, Issue:3 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Aphidicolin; Apoptosis; Camptothecin; Cell Cycle; Cell Death; Cisplatin; Culture Media, Serum-Free; Doxorubicin; Enzyme Inhibitors; Fas Ligand Protein; fas Receptor; Gene Expression; HeLa Cells; Humans; Hydroxyurea; Jurkat Cells; Membrane Glycoproteins; Nimustine; Nocodazole; Paclitaxel; Sensitivity and Specificity; Teniposide; Tumor Cells, Cultured; Vincristine	1998
Combined cytotoxic effects of tumor necrosis factor-alpha with various cytotoxic agents in tumor cell lines that are drug resistant due to mutated p53. Journal of immunotherapy (Hagerstown, Md. : 1997), 1999, Volume: 22, Issue:1 Topics: Antineoplastic Agents; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Genes, p53; Humans; Melphalan; Mitoxantrone; Mutation; Ovarian Neoplasms; Paclitaxel; Teniposide; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Vinblastine	1999
Accumulation of mutant p53(V143A) modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells independent of endogenous p53 status. Experimental cell research, 1999, Dec-15, Volume: 253, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Camptothecin; Carmustine; Cell Death; Cell Division; Cisplatin; Clone Cells; Combined Modality Therapy; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Gene Expression Regulation, Neoplastic; Genes, Dominant; Glioma; Humans; In Vitro Techniques; Paclitaxel; Point Mutation; Radiotherapy; Teniposide; Topotecan; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vincristine	1999
Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2001, Volume: 32, Issue:2 Topics: Amino Acid Substitution; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Biomarkers; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; DNA Mutational Analysis; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Isoenzymes; Ki-67 Antigen; Life Tables; Lung Neoplasms; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation, Missense; Neoplasm Proteins; Paclitaxel; Point Mutation; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Survival Analysis; Teniposide; Topotecan; Treatment Outcome; Vault Ribonucleoprotein Particles	2001
Paclitaxel and lung cancer: new preparation. No therapeutic progress. Prescrire international, 2000, Volume: 9, Issue:46 Topics: Antineoplastic Agents, Phytogenic; Cisplatin; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Paclitaxel; Teniposide; Treatment Outcome	2000
[Chemosensitivity testing of oral and maxillofacial cancer with biopsy specimens]. Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology, 2002, Volume: 37, Issue:6 Topics: Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Maxilla; Maxillary Neoplasms; Mouth; Mouth Neoplasms; Paclitaxel; Teniposide; Tumor Cells, Cultured; Vindesine	2002
Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Apr-01, Volume: 11, Issue:7 Topics: Antibiotics, Antineoplastic; bcl-2-Associated X Protein; Blotting, Western; Breast Neoplasms; Camptothecin; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Clone Cells; Cyclin-Dependent Kinase Inhibitor p21; Doxorubicin; Drug Resistance, Neoplasm; Gamma Rays; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Immediate-Early Proteins; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Telomerase; Teniposide; Tumor Suppressor Protein p53; Tumor Suppressor Proteins	2005
Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS. Journal of experimental & clinical cancer research : CR, 2011, Oct-05, Volume: 30 Topics: Adverse Drug Reaction Reporting Systems; Antineoplastic Agents; Asparaginase; Bayes Theorem; Data Mining; Docetaxel; Drug Hypersensitivity; Etoposide; Humans; Paclitaxel; Pharmacovigilance; Procarbazine; Prognosis; Taxoids; Teniposide; United States; United States Food and Drug Administration	2011